Next Generation Of Hormone Therapies


We are dedicated to discovering, acquiring, and
developing novel compounds to treat hormone responsive cancers

Blue gloved hands holding open a drug capsule with colorful balls inside.jpg

Our Science

Sigma1 Icon

Program Highlight

Sigma1 is a stabilizing protein that regulates client protein quality control and transport.

Therapeutic Focus Icon

Therapeutic Focus

Prostate, breast, and gastrointestinal cancers.

Biomarkers Icon


Context has developed biomarker tools to identify those patients who are most likely to our therapies.

our team

We are building Context Therapeutics to become a global company that will discover, develop and market groundbreaking cancer treatments to patients around the world, eliminating the fear that comes with a cancer diagnosis.

+ meet the team

Our Partners

The best ideas are often developed through external collaboration. To facilitate collaboration, our Team makes available to academic labs and private research institutes our "Toolkits" that contain proprietary compounds, screening assays, reagents, and tools. The goal of these relationships is to expand our current knowledge of Context's Core Indications and to find new uses of our compounds to treat diseases of significant unmet medical need.

Young scientist mixing drugs for drug discovery trials in colorful lab